269 related articles for article (PubMed ID: 29227847)
1. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
van Niekerk CC; van Dijck JAAM; Verbeek ALM
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847
[TBL] [Abstract][Full Text] [Related]
2. Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
Grandi G; Perrone AM; Chiossi G; Friso S; Toss A; Sammarini M; Facchinetti F; Botticelli L; Palma F; De Iaco P
Gynecol Oncol; 2019 Jul; 154(1):163-168. PubMed ID: 31104904
[TBL] [Abstract][Full Text] [Related]
3. Population-based analysis of pathologic data: a new approach to the investigation of uterine endometrial and ovarian endometrioid carcinomas.
Henson DE; Schwartz AM; Tilara A; Grimley PM; Anderson WF
Arch Pathol Lab Med; 2007 Sep; 131(9):1337-42. PubMed ID: 17824787
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
[TBL] [Abstract][Full Text] [Related]
6. Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.
Storey DJ; Rush R; Stewart M; Rye T; Al-Nafussi A; Williams AR; Smyth JF; Gabra H
Cancer; 2008 May; 112(10):2211-20. PubMed ID: 18344211
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
[TBL] [Abstract][Full Text] [Related]
8. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
9. The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.
Kok VC; Tsai HJ; Su CF; Lee CK
Int J Gynecol Cancer; 2015 Jul; 25(6):968-76. PubMed ID: 25893280
[TBL] [Abstract][Full Text] [Related]
10. Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands.
Burg L; Timmermans M; van der Aa M; Boll D; Rovers K; de Hingh I; van Altena A
J Gynecol Oncol; 2020 Sep; 31(5):e58. PubMed ID: 32808491
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
12. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the risk of malignancy index and the risk of ovarian malignancy algorithm in a cohort of women with ovarian cancer: does histotype and stage matter?
Lennox GK; Eiriksson LR; Reade CJ; Leung F; Mojtahedi G; Atenafu EG; Ferguson SE; Murphy J; Diamandis EP; Kulasingam V; Bernardini MQ
Int J Gynecol Cancer; 2015 Jun; 25(5):809-14. PubMed ID: 25855958
[TBL] [Abstract][Full Text] [Related]
14. Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register.
Trabert B; Aarestrup J; Ulrich LG; Wentzensen N; Sørensen TIA; Baker JL
Gynecol Oncol; 2018 Mar; 148(3):547-552. PubMed ID: 29331371
[TBL] [Abstract][Full Text] [Related]
15. Synchronous primary cancers of the endometrium and ovary in young women: a Korean Gynecologic Oncology Group Study.
Song T; Seong SJ; Bae DS; Suh DH; Kim DY; Lee KH; Lim MC; Lee TS
Gynecol Oncol; 2013 Dec; 131(3):624-8. PubMed ID: 24051220
[TBL] [Abstract][Full Text] [Related]
16. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.
Nishimura S; Ito YM; Tsuda H; Ohnishi Y; Kataoka F; Nomura H; Chiyoda T; Suzuki A; Susumu N; Aoki D; Hatae M
Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):67-72. PubMed ID: 19815329
[TBL] [Abstract][Full Text] [Related]
18. Squash cytodiagnosis of synchronous papillary serous carcinoma of ovary and endometrium with demonstration of serous tubal intraepithelial carcinoma as a precursor lesion.
Kar A; Kar T; Dha I; Panda S
Indian J Pathol Microbiol; 2017; 60(1):125-127. PubMed ID: 28195111
[No Abstract] [Full Text] [Related]
19. [Endometrial cancer, turned out to be an endometroid ovarian cancer stage II].
Lazarov N; Lazarov L; Laarov S; Velev V; Ananiev J
Akush Ginekol (Sofiia); 2011; 50(6):48-50. PubMed ID: 22452068
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of matrix metalloproteinases 2 and 9 in endometrial cancer.
Puljiz M; Puljiz Z; Vucemilo T; Ramić S; Knezević F; Culo B; Alvir I; Tomica D; Danolić D
Coll Antropol; 2012 Dec; 36(4):1367-72. PubMed ID: 23390835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
